| Ingredient | Concerns | Score |
|---|---|---|
| PROPYLPARABEN | Developmental/reproductive toxicity, Ecotoxicology, Endocrine disruption, Allergies/immunotoxicity, Use restrictions |  Data: Limited |
| BUTYLPARABEN | Biochemical or cellular level changes, Data gaps, Developmental/reproductive toxicity, Endocrine disruption, Allergies/immunotoxicity, Use restrictions | Data: Limited |
| CITRUS NOBILIS (MANDARIN ORANGE) PEEL OIL | Organ system toxicity (non-reproductive), Use restrictions | Data: Limited |
| ETHYLPARABEN | Endocrine disruption, Allergies/immunotoxicity, Use restrictions | Data: Limited |
| METHYLPARABEN | Biochemical or cellular level changes, Endocrine disruption, Allergies/immunotoxicity, Use restrictions | Data: Limited |
| PHENOXYETHANOL | Allergies/immunotoxicity, Irritation (skin, eyes, or lungs), Organ system toxicity (non-reproductive), Occupational hazards, Use restrictions | Data: Limited |
| PEG-12 GLYCERYL DISTEARATE | Contamination concerns (ETHYLENE OXIDE, 1,4-DIOXANE), Organ system toxicity (non-reproductive) |  Data: None |
| PEG-40 HYDROGENATED CASTOR OIL | Contamination concerns (ETHYLENE OXIDE, 1,4-DIOXANE, ETHYLENE OXIDE, 1,4-DIOXANE), Organ system toxicity (non-reproductive), Use restrictions | Data: Limited |
| PPG-26-BUTETH-26 | Multiple, additive exposure sources, Contamination concerns (BUTYL ALCOHOL), Organ system toxicity (non-reproductive) |  Data: Limited |
| FULLERENE (C60 HYDROXIDE) FULLERENES | Enhanced skin absorption, Biochemical or cellular level changes, Cancer |  Data: Fair |
| BUTYLENE GLYCOL | Irritation (skin, eyes, or lungs) | Data: Limited |
| PVP | Organ system toxicity (non-reproductive) | Data: Fair |
| AMMONIUM ACRYLOYLDIMETHYL TAURATE/ VP COPOLYMER | None Identified |  Data: None |
| AMINOETHYLPHOSPHINIC ACID | None Identified | Data: None |
| CAMELLIA OLEIFERA (TEA-OIL CAMELLIA) LEAF EXTRACT CAMELLIA OLEIFERA LEAF EXTRACT | None Identified | Data: Limited |
| WATER | Innocuous | Data: Robust |
